Company

KeyDev Inc. is a young start-up that is pushing the boundaries of innovation and challenging the status quo. KeyDev Inc's latest solution KeyGel system is poised to truly disrupt the slab gel electrophoresis industry with its numerous advantages over the current standard. Our solution boasts a number of benefits that are sure to appeal to any molecular biology lab. The most notable of these include a lower cost, faster set up time, faster runtime, smaller footprint, lower reagent volumes and the flexibility to use in-house reagents. These benefits are made possible by our cutting-edge technology and exceptional team, which are committed to delivering the best possible solutions to our customers. We are confident that our solution will be a game changer in the industry and we look forward to its widespread adoption

The Boston based company is led by Dr. Deepak Dibya, a highly accomplished professional with a Ph.D. in Bioanalytical Sciences and more than two decades of experience in the biotech industry. Dr. Dibya's expertise spans a broad range of domains within the life sciences field, including genomics, diagnostics, oncology, pharma, and health informatics. Dr. Dibya has an impressive track record of contributing to the development and launch of innovative biotech products that have generated significant revenue streams. Also, he has been instrumental in the successful acquisition of several start-ups by larger companies.

Dr. Dibya has assembled a team of brilliant scientists and engineers, who collectively boast over 80 years of experience in the industry. Under Dr. Dibya's visionary leadership, KeyDev Inc. is passionately dedicated to advancing the frontiers of life sciences through cutting-edge research and the development of groundbreaking products that have the power to transform and improve laboratory processes. The company's unwavering commitment to delivering high-quality solutions that cater to the needs of researchers sets it apart, while its dedication to contributing to the growth and success of the biotech industry as a whole makes it a true beacon of innovation and progress.